Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

PE Van den Steen, B Dubois, I Nelissen… - Critical reviews in …, 2002 - Taylor & Francis
The matrix metalloproteinases (MMPs) form an enzyme family of which gelatinase B (MMP-
9) represents the largest and most complex member. We focus here on the biochemical …

Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) epidemiology and pathogenesis

LA Dourmishev, AL Dourmishev… - Microbiology and …, 2003 - Am Soc Microbiol
Kaposi's sarcoma had been recognized as unique human cancer for a century before it
manifested as an AIDS-defining illness with a suspected infectious etiology. The discovery of …

[HTML][HTML] Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American …

DT Azar - Transactions of the American Ophthalmological Society, 2006 - ncbi.nlm.nih.gov
Purpose To determine the molecular basis of corneal avascularity during wound healing
and determine the role of angiogenic and antiangiogenic factors in corneal vasculogenesis …

Kaposi sarcoma: a continuing conundrum

RA Schwartz, G Micali, MR Nasca, L Scuderi - Journal of the American …, 2008 - Elsevier
Kaposi sarcoma (KS) remains a challenge. Its classic or Mediterranean form tends to be
benign. In transplant recipients it may be less so. As part of the AIDS pandemic, of which it …

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

C Sgadari, G Barillari, E Toschi, D Carlei… - Nature medicine, 2002 - nature.com
Abstract Treatment with HIV-1 protease inhibitors (PI) is associated with a reduced incidence
or regression of Kaposi sarcoma (KS). Here we show that systemic administration of the PIs …

Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases

NL Webster, SM Crowe - Journal of leukocyte biology, 2006 - academic.oup.com
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that are a subfamily
of metzincins. Matrix metalloproteinases are responsible for much of the turnover of extra …

Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study

BJ Dezube, SE Krown, JY Lee, KS Bauer… - Journal of clinical …, 2006 - ascopubs.org
Purpose Matrix metalloproteinases (MMPs) are involved in tumor metastasis and are
overexpressed in Kaposi's sarcoma (KS) cells. In a phase I trial of the MMP inhibitor COL-3 …

Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth

C Sgadari, P Monini, G Barillari, B Ensoli - The lancet oncology, 2003 - thelancet.com
HIV protease inhibitors are antiretroviral drugs that block the enzyme required for production
of infectious viral particles. Although these agents have been designed to selectively bind to …

Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations

T Lammers - Advanced drug delivery reviews, 2010 - Elsevier
Copolymers based on N-(2-hydroxypropyl) methacrylamide (HPMA) are prototypic and well-
characterized polymeric drug carriers that have been broadly implemented in the delivery of …

Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems

T Lammers, P Peschke, R Kühnlein, V Subr… - Journal of controlled …, 2007 - Elsevier
Copolymers of N-(2-hydroxypropyl) methacrylamide (HPMA) are prototypic and well-
characterized polymeric drug carriers that have been broadly implemented in the delivery of …